Crinetics Pharmaceuticals CRNX Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Crinetics Pharmaceuticals's preferred stock, shares outstanding?
- Crinetics Pharmaceuticals (CRNX) reported preferred stock, shares outstanding of $0 in Q1 2026.